https://bindralab.org/publications/radiation-sensitivity-and-sensitization-in-melanoma/2013-12-05T23:57:23+00:00https://bindralab.org/publications/development-of-an-assay-to-measure-mutagenic-non-homologous-end-joining-repair-activity-in-mammalian-cells-nucleic/2013-12-05T23:57:40+00:00https://bindralab.org/publications/the-important-role-of-radiation-therapy-in-early-stage-diffuse-large-b-cell-lymphoma-time-to-review-the-evidence-once-again/2013-12-05T23:57:57+00:00https://bindralab.org/publications/inhibition-of-polyadp-ribose-polymerase-down-regulates-brca1-and-rad51-in-a-pathway-mediated-by-e2f4-and-p130/2013-12-06T00:04:13+00:00https://bindralab.org/publications/targeting-the-dna-damage-response-for-cancer-therapy/2013-12-05T23:58:25+00:00https://bindralab.org/publications/introduction-the-evolving-picture-of-the-hypoxic-tumour-microenvironment/2013-12-05T23:58:44+00:00https://bindralab.org/publications/co-repression-of-mismatch-repair-gene-expression-by-hypoxia-in-cancer-cells-role-of-the-mycmax-network/2013-12-05T23:59:08+00:00https://bindralab.org/publications/regulation-of-dna-repair-in-hypoxic-cancer-cells/2013-12-05T23:59:42+00:00https://bindralab.org/publications/repression-of-rad51-gene-expression-by-e2f4p130-complexes-in-hypoxia/2013-12-06T00:00:05+00:00https://bindralab.org/publications/hypoxia-induced-genetic-instability-a-calculated-mechanism-underlying-tumor-progression/2013-12-06T00:00:20+00:00https://bindralab.org/publications/basal-repression-of-brca1-by-multiple-e2fs-and-pocket-proteins-at-adjacent-e2f-sites/2013-12-06T00:00:50+00:00https://bindralab.org/publications/chk2-dependent-phosphorylation-of-brca1-in-hypoxia/2013-12-06T00:00:35+00:00https://bindralab.org/publications/hypoxia-induced-down-regulation-of-brca1-expression-by-e2fs/2013-12-06T00:01:23+00:00https://bindralab.org/publications/hypoxia-induced-phosphorylation-of-chk2-in-an-ataxia-telangiectasia-mutated-dependent-manner/2013-12-06T00:01:07+00:00https://bindralab.org/publications/alterations-in-dna-repair-gene-expression-under-hypoxia-elucidating-the-mechanisms-of-hypoxia-induced-genetic-instability/2013-12-06T00:01:42+00:00https://bindralab.org/publications/hypoxia-down-regulates-dna-double-strand-break-repair-gene-expression-in-prostate-cancer-cells/2013-12-06T00:01:57+00:00https://bindralab.org/publications/genetic-instability-and-the-tumor-microenvironment-towards-the-concept-of-microenvironment-induced-mutagenesis/2013-12-06T00:02:13+00:00https://bindralab.org/publications/down-regulation-of-rad51-and-decreased-homologous-recombination-in-hypoxic-cancer-cells/2013-12-06T00:02:27+00:00https://bindralab.org/publications/decreased-expression-of-the-dna-mismatch-repair-gene-mlh1-under-hypoxic-stress-in-mammalian-cells/2013-12-06T00:02:43+00:00https://bindralab.org/publications/vhl-mediated-hypoxia-regulation-of-cyclin-d1-in-renal-carcinoma-cells/2013-12-06T00:02:57+00:00https://bindralab.org/publications/mutations-in-the-chloride-channel-gene-clcnkb-cause-bartters-syndrome-type-iii/2013-12-06T00:03:18+00:00https://bindralab.org/publications/the-additive-effects-of-smoking-and-hypertension-more-reasons-to-help-your-patients-kick-the-habit/2013-12-06T00:03:33+00:00https://bindralab.org/publications/2-hydroxyglutarate-produced-by-neomorphic-idh-mutations-suppresses-homologous-recombination-and-induces-parp-inhibitor-sensitivity/2021-06-23T17:24:00+00:00https://bindralab.org/publications/krebs-cycle-deficient-hereditary-cancer-syndromes-are-defined-by-defects-in-homologous-recombination-dna-repair/2021-06-23T17:25:46+00:00https://bindralab.org/publications/temozolomide-sensitizes-mgmt-deficient-tumor-cells-to-atr-inhibitors/2021-06-23T17:27:03+00:00https://bindralab.org/publications/ppm1d-mutations-silence-naprt-gene-expression-and-confer-nampt-inhibitor-sensitivity-in-glioma/2021-06-23T17:27:56+00:00https://bindralab.org/publications/oncometabolites-suppress-dna-repair-by-disrupting-local-chromatin-signalling/2021-06-23T17:28:58+00:00https://bindralab.org/publications/creation-of-a-new-class-of-radiosensitizers-for-glioblastoma-based-on-the-mibefradil-pharmacophore/2021-06-23T17:30:32+00:00https://bindralab.org/publications/targeting-idh1-2-mutant-cancers-with-combinations-of-atr-and-parp-inhibitors/2021-06-23T17:31:16+00:00https://bindralab.org/publications/loss-of-atrx-confers-dna-repair-defects-and-parp-inhibitor-sensitivity/2021-06-23T17:32:10+00:00https://bindralab.org/publications/936/2021-06-23T17:34:42+00:00